Skip to main content
Equibles
IPHA logo

IPHA · Innate Pharma SA

Track IPHA — free

Use IPHA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about IPHA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.18 -0.36 (-14.00%) At close · Aug 14
Market Cap
$204.71M
Shares
93.90M

Innate Pharma SA Earnings Call Transcripts

Every quarterly earnings call for Innate Pharma SA (IPHA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-14
Earnings conference call (announced in 6-K)
Confident tone IPH4502 Nectin-4 ADC Monalizumab / Pacific 9 ADC preclinical portfolio
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Earnings conference call (announced in 6-K)
Confident tone Catalysts and upcoming milestones Monalizumab / Pacific 9 Phase 3 NSCLC AstraZeneca collaboration economics
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Innate Pharma SA Q1 FY2026 Earnings Call
Positive tone IPH4502 Nectin-4 ADC program Lacutamab CTCL program and TELLOMAK-3 Phase III Monalizumab and AstraZeneca partnership
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q4
2025-12-31
Innate Pharma SA Q4 FY2025 Earnings Call
Positive tone IPH4502 Nectin-4 ADC program Lacutamab CTCL program and TELLOMAK-3 Phase III Monalizumab and AstraZeneca partnership
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Innate Pharma SA Q3 FY2025 Earnings Call
Confident tone IPH4502 ADC Monalizumab PACIFIC-9 Regulatory milestones and FDA interaction
Results not yet reported
Audio Transcript Slides 8-K10-Q
Annual General Meeting
Investor event
2025-09-25
Individual shareholders meeting
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-06-26
Innate Pharma SA Q2 FY2025 Earnings Call
Positive tone Lacutamab Phase III Plans and Partnering IPH4502 Nectin-4 ADC Differentiation and Opportunity IPH4502 Phase I Clinical Progress and Milestones
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Innate Pharma SA Q1 FY2025 Earnings Call
Positive tone ADC programs ANKET NK-Cell Engager platform Lacutamab partnership and development
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Innate Pharma SA Q3 FY2024 Earnings Call
Positive tone IPH4502 Nectin-4 ADC ANKET NK cell engager platform Partnership and licensing strategy
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-25
Innate Pharma SA Q2 FY2024 Earnings Call
Balanced tone Lacutamab / TELLOMAK in CTCL IPH45 / Nectin-4 ADC Partnerships (Sanofi, AstraZeneca, Takeda)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Innate Pharma SA Q1 FY2024 Earnings Call
Balanced tone ADC pipeline expansion ANKET NK cell engager platform AstraZeneca partnership and monalizumab
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Innate Pharma SA Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Innate Pharma SA Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-28
Innate Pharma SA Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Innate Pharma SA Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Innate Pharma SA Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Innate Pharma SA Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-24
Innate Pharma SA Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Innate Pharma SA Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Innate Pharma SA Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-23
Innate Pharma SA Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Innate Pharma SA Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 9 filings 9 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)